Gri bio granted japan patent for proprietary natural killer t (nkt) cell modulators for prevention and treatment of inflammatory conditions

Company continues to advance an innovative pipeline of nkt cell regulators for the treatment of high-value inflammatory, fibrotic and autoimmune diseases

GRI Ratings Summary

GRI Quant Ranking